Previous 10 | Next 10 |
Psychemedics ( PMD ) focuses on its patented hair-based drug-testing system. The drug and alcohol testing market is a $6 billion market that is expected to grow at a high single-digit rate in the coming years. The two general macro drivers behind the expectation include stricter legal environm...
By Felipe Bijit and Stefan Larsen Psychedemics Corporation ( PMD ), as might be expected from a micro-cap stock, has what we might consider a divided personality. On the one hand, the company offers the possibility of returns through its unique technology allowing for organic growth. On th...
It probably doesn't happen very often - an investment thesis playing out exactly as planned. In fact, some advisors propose an investor's exit strategy is more important than their entrance strategy. Ironically though, most investors are probably not nearly as willing to admit when an investme...
Psychemedics (NASDAQ: PMD ) announces that the FDA has cleared its test for the synthetic opioid fentanyl using hair samples. More news on: Psychemedics Corporation, Healthcare stocks news, Read more ...
ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s first and only FDA-cleared hair test for Fentanyl, a major killer increasingly fou...
Psychemedics (NASDAQ: PMD ): Q1 GAAP EPS of $0.11. More news on: Psychemedics Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
ACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of May 7,...
Psychemedics ( PMD ) provides drug testing via hair analysis. This is an asset-light business that has resulted in this small-cap generating impressive free cash flow over the years. 2018 marked the third consecutive year of record revenue. Domestic revenue grew by 11%, which is slightly above...
SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader in detecting drugs of abuse using hair analysis, today at the National Drug and Alcohol Screening Association (NDASA) Conference introduced the industry’s fir...
Gainers: Document Security Systems (NYSEMKT: DSS ) +57% . Cool Holdings (NASDAQ: AWSM ) +38% . Fuwei Films (NASDAQ: FFHL ) +30% . China Rapid Finance (NYSE: XRF ) +23% . Ctrip.com International (NASDAQ: CTRP ) +21% . Aqua Metals (NASDAQ: AQMS ) +18% . BioHiTech Global (NASDAQ: ...
News, Short Squeeze, Breakout and More Instantly...
Psychemedics Corporation Company Name:
PMD Stock Symbol:
NASDAQ Market:
Psychemedics Corporation Website:
DALLAS, June 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, proudly presents its inaugural Insights Report. This groundbreaking report offers a comprehensive analysis of drug trends in the workplace, drawing insights from a...
DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2024. The Company’s revenue for the quarter ended March 31,...
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023. “2023 proved to be another challenging year due to the nega...